Emiko Sakaida

2.1k total citations
103 papers, 866 citations indexed

About

Emiko Sakaida is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Emiko Sakaida has authored 103 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Hematology, 28 papers in Oncology and 17 papers in Molecular Biology. Recurrent topics in Emiko Sakaida's work include Acute Myeloid Leukemia Research (18 papers), Chronic Myeloid Leukemia Treatments (16 papers) and Hematopoietic Stem Cell Transplantation (13 papers). Emiko Sakaida is often cited by papers focused on Acute Myeloid Leukemia Research (18 papers), Chronic Myeloid Leukemia Treatments (16 papers) and Hematopoietic Stem Cell Transplantation (13 papers). Emiko Sakaida collaborates with scholars based in Japan, United States and United Kingdom. Emiko Sakaida's co-authors include Chiaki Nakaseko, Chikako Ohwada, Masahiro Takeuchi, Yusuke Takeda, Naomi Shimizu, Miki Nishimura, Yasushi Saitō, Akira Yokota, Tohru Iseki and Shokichi Tsukamoto and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Emiko Sakaida

93 papers receiving 850 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emiko Sakaida Japan	17	373	186	160	160	149	103	866
Yair Herishanu Israel	15	175 0.5×	279 1.5×	96 0.6×	70 0.4×	207 1.4×	36	1.0k
Dina Attias Israel	16	205 0.5×	218 1.2×	44 0.3×	73 0.5×	215 1.4×	46	864
L. Brugiéres France	12	244 0.7×	265 1.4×	104 0.7×	181 1.1×	172 1.2×	28	789
Katsumichi Fujimaki Japan	19	419 1.1×	330 1.8×	77 0.5×	107 0.7×	254 1.7×	85	1.1k
Stephen H. Nantel Canada	20	684 1.8×	303 1.6×	63 0.4×	177 1.1×	386 2.6×	74	1.3k
Takahiko Sugihara Japan	16	166 0.4×	93 0.5×	78 0.5×	38 0.2×	139 0.9×	72	1.0k
Stephanie Gregory United States	13	331 0.9×	379 2.0×	63 0.4×	118 0.7×	158 1.1×	26	963
Fumihiko Ishimaru Japan	21	358 1.0×	309 1.7×	83 0.5×	29 0.2×	125 0.8×	93	1.1k
Andreas K. Klein United States	15	271 0.7×	350 1.9×	38 0.2×	83 0.5×	95 0.6×	54	731
M. Burk Germany	15	188 0.5×	209 1.1×	85 0.5×	55 0.3×	71 0.5×	21	944

Countries citing papers authored by Emiko Sakaida

Since Specialization

Citations

This map shows the geographic impact of Emiko Sakaida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emiko Sakaida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emiko Sakaida more than expected).

Fields of papers citing papers by Emiko Sakaida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emiko Sakaida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emiko Sakaida. The network helps show where Emiko Sakaida may publish in the future.

Co-authorship network of co-authors of Emiko Sakaida

This figure shows the co-authorship network connecting the top 25 collaborators of Emiko Sakaida. A scholar is included among the top collaborators of Emiko Sakaida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emiko Sakaida. Emiko Sakaida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shimizu, Hiroaki, Yuho Najima, Shinichi Kako, et al.. (2024). Treatment Outcomes of Adult Patients with B-Cell Acute Lymphoblastic Leukemia Relapsed after Allogeneic Stem Cell Transplant in the Era of Novel Immunochemotherapeutic Agents. Blood. 144(Supplement 1). 3541–3541.

Bolanos, Lyndsey, Kwangmin Choi, Shokichi Tsukamoto, et al.. (2024). Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression. Leukemia. 38(5). 1032–1045. 3 indexed citations

Tsukamoto, Shokichi, Yusuke Takeda, Chikako Ohwada, et al.. (2024). Clinical impact of airflow obstruction after allogeneic hematopoietic stem cell transplantation. International Journal of Hematology. 120(4). 501–511. 1 indexed citations

Itonaga, Hidehiro, Hideyuki Nakazawa, Tetsuya Nishida, et al.. (2024). Superior Survival After Unrelated Allogeneic Stem Cell Transplantation With Low-Dose ATG Compared to Low-Dose TBI in Myeloablative Fludarabine/Busulfan-Based Regimen for MDS on Behalf of the Adult MDS Working Group of the JSTCT. Transplantation and Cellular Therapy. 31(1). 18.e1–18.e12. 1 indexed citations

Hayakawa, Fumihiko, Naoki Mori, Kiyotoshi Imai, et al.. (2024). Nelarabine‐combined chemotherapy improves outcome of T‐cell acute lymphoblastic leukemia but shows more severe neurotoxicity: JALSG T‐ALL213‐O. Cancer Science. 116(2). 453–461. 1 indexed citations

Muraosa, Yasunori, Yutaro Hino, Shogo Takatsuka, et al.. (2024). Fungal chitin-binding glycoprotein induces Dectin-2-mediated allergic airway inflammation synergistically with chitin. PLoS Pathogens. 20(1). e1011878–e1011878. 4 indexed citations

Toya, Takashi, Masatoshi Sakurai, Jun Kato, et al.. (2023). Differential clinical impact of letermovir prophylaxis according to graft sources: a KSGCT multicenter retrospective analysis. Blood Advances. 8(5). 1084–1093. 4 indexed citations

Sato, Aki, Masayuki Kobayashi, Miho Ogawa, et al.. (2023). Clinical and prognostic features of Langerhans cell histiocytosis in adults. Cancer Science. 114(9). 3687–3697. 7 indexed citations

Nakamae, Hirohisa, Masahide Yamamoto, Emiko Sakaida, et al.. (2021). Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial. International Journal of Hematology. 115(1). 33–42. 8 indexed citations

10.

Ohwada, Chikako, Shingo Yamazaki, Katsuhiro Shono, et al.. (2021). Pharmacokinetically guided, once-daily intravenous busulfan in combination with fludarabine for elderly AML/MDS patients as a conditioning regimen for allogeneic stem cell transplantation. International Journal of Hematology. 114(6). 664–673. 2 indexed citations

11.

Shimazu, Yutaka, Shohei Mizuno, Shin‐ichi Fuchida, et al.. (2021). Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine. Cancer Science. 112(12). 5034–5045. 11 indexed citations

12.

Takamatsu, Hiroyuki, Naoki Takezako, Takeshi Yamashita, et al.. (2020). Minimal Residual Disease in Autografts and Bone Marrow of Patients with Multiple Myeloma: 8-Color Multiparameter Flow Cytometry (EuroFlow-NGF) Vs. Next-Generation Sequencing. Blood. 136(Supplement 1). 22–23. 2 indexed citations

13.

Ohwada, Chikako, Yutaro Hino, Kensuke Kayamori, et al.. (2020). Successful second autologous stem-cell transplantation for patients with relapsed and refractory POEMS syndrome. Bone Marrow Transplantation. 56(2). 517–520. 6 indexed citations

14.

Isshiki, Yusuke, Yaeko Nakajima‐Takagi, Motohiko Oshima, et al.. (2019). KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesis. Blood Advances. 3(17). 2537–2549. 20 indexed citations

15.

Nakamura, Ayako, Chikako Ohwada, Masahiro Takeuchi, et al.. (2019). Detection of MYD88 L265P mutation by next-generation deep sequencing in peripheral blood mononuclear cells of Waldenström’s macroglobulinemia and IgM monoclonal gammopathy of undetermined significance. PLoS ONE. 14(9). e0221941–e0221941. 12 indexed citations

16.

Muto, Tomoya, Naoya Mimura, Shokichi Tsukamoto, et al.. (2018). Long-term complete remission following tandem autologous stem cell transplantation and consolidative radiotherapy for refractory mediastinal gray-zone lymphoma. International Journal of Hematology. 108(4). 452–455. 2 indexed citations

17.

Shimizu, Naomi, Tomoya Muto, Shokichi Tsukamoto, et al.. (2018). Long-term efficacy of partial splenic embolization for the treatment of steroid-resistant chronic immune thrombocytopenia. Annals of Hematology. 97(4). 655–662. 17 indexed citations

18.

Ohwada, Chikako, Emiko Sakaida, Tomoya Muto, et al.. (2018). Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome. Blood. 131(19). 2173–2176. 23 indexed citations

19.

Isshiki, Yusuke, Chikako Ohwada, Emiko Sakaida, et al.. (2017). CD20 positivity and white blood cell count predict treatment outcomes in Philadelphia chromosome-negative acute lymphoblastic leukemia patients ineligible for pediatric-inspired chemotherapy. Japanese Journal of Clinical Oncology. 47(11). 1047–1054. 3 indexed citations

20.

Misawa, Sonoko, Yasunori Sato, K. Katayama, et al.. (2015). Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study. BMJ Open. 5(11). e009157–e009157. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact